title: The effect of omalizumab dosing and frequency in chronic idiopathic urticaria: Retrospective chart review.
authors.affiliation: Department of Dermatology, University of Utah, Salt Lake City, Utah.
authors.forename: Joshua J
authors.initials: JJ
authors.lastname: Clark
authors.affiliation: Department of Dermatology, University of Utah, Salt Lake City, Utah.
authors.forename: Aaron M
authors.initials: AM
authors.lastname: Secrest
authors.affiliation: Department of Dermatology, University of Utah, Salt Lake City, Utah.
authors.forename: Christopher M
authors.initials: CM
authors.lastname: Hull
authors.affiliation: Department of Dermatology, University of Utah, Salt Lake City, Utah.
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Eliason
authors.affiliation: Department of Dermatology, University of Utah, Salt Lake City, Utah.
authors.forename: Kristin M
authors.initials: KM
authors.lastname: Leiferman
authors.affiliation: Department of Dermatology, University of Utah, Salt Lake City, Utah.
authors.forename: Gerald J
authors.initials: GJ
authors.lastname: Gleich
authors.affiliation: Department of Dermatology, University of Utah, Salt Lake City, Utah. Electronic address: douglas.powell@hsc.utah.edu.
authors.forename: Douglas L
authors.initials: DL
authors.lastname: Powell
mesh_terms: D000328:Adult; D018926:Anti-Allergic Agents / Q000008:administration & dosage*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069444:Omalizumab / Q000008:administration & dosage*; D012189:Retrospective Studies; D012720:Severity of Illness Index; D014581:Urticaria / Q000188:drug therapy*
chemical_list: D018926:Anti-Allergic Agents; D000069444:Omalizumab